Angelos Hatzakis, MD, PhD
National and Kapodistrian University of Athens Medical School - Professor of Epidemiology & Preventive Medicine
PhD, Epidemiology, National and Kapodistrian University of Athens
MD, Medicine, National and Kapodistrian University of Athens
MSc, Epidemiology, Harvard School of Public Health
Research Interests
Epidemiology/public health, Molecular epidemiology, HIV/AIDS, Viral hepatitis
Angelos Hatzakis’ research interests cover epidemiology, virology, preventive medicine, public health of infectious diseases – especially HIV/AIDS – hepatitis and other oncogenic viruses. He has published over 280 international scientific articles and has more than 13,000 citations. Dr. Hatzakis is the founder of the National Retrovirus Reference Center, Athens, Greece; former president of the Hellenic Center for Disease Control & Prevention; founder and co-chair of “Hepatitis B & C Public Policy Association” in Luxembourg.


Uuskula A, Rannap J, Weijler L..., Des Jarlais D..., Hatzakis A..., EMCDDA Study Group (2023).
Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies
Addiction, 118 (11), 2177-2192. doi: 10.1111/add.16283.

Sypsa V, Roussos S, Tsirogianni E, Tsiara C, Paraskeva D, Chrysanthidis T, Chatzidimitriou D, Papadimitriou E, Paraskevis D, Goulis I, Kalamitsis G, Hatzakis A (2023).
A new outbreak of HIV infection among people who inject drugs during the COVID-19 pandemic in Greece
International Journal of Drug Policy, 117, 104073. doi: 10.1016/j.drugpo.2023.104073. PMCID: PMC10201320.

Wiessing L, Sypsa V, Abagiu AO, ... Feelemyer J, ...Hatzakis A..., Des Jarlais D (2023).
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel
AIDS and Behavior, 27 (4), 1140-1153. doi: 10.1007/s10461-022-03851-x. PMCID: PMC9651099.

Wedemeyer H, Tergast TL, Lazarus JV, Razavi H..., Hatzakis A (2023).
Securing wider EU commitment to the elimination of hepatitis C virus
Liver International, 43 (2), 276-291. doi: 10.1111/liv.15446.

Roussos S, Paraskevis D, Malliori M, Hatzakis A, Sypsa V (2023).
Estimating the number of people who inject drugs using repeated respondent-driven sampling (RDS) in a community-based program: Implications for the burden of hepatitis C and HIV infections and harm reduction coverage
AIDS and Behavior, 27 (2), 424-430. doi: 10.1007/s10461-022-03777-4.


Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC (2015).
Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: The ARISTOTLE programme
Addiction, 110 (9), 1453-1467. doi: 10.1111/add.12999. PMCID: PMC4854521.

Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, Katsoulidou A, Psichogiou M, Fotiou A, Pharris A, Van De Laar M, Wiessing L, Des Jarlais D, Friedman SR, Hatzakis A (2015).
Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece
American Journal of Public Health, 105 (1), 196-204. doi: 10.2105/AJPH.2013.301656. PMCID: PMC4145040.

Dr. Hatzakis' Google Scholar Profile